Staphylococcus aureus is a common clinical pathogen that can cause a variety of diseases, such as osteomyelitis, endocarditis, indwelling device infections, and wound infections. Infections caused by Staphylococcus aureus, including methicillin-resistant staphylococcus aureus (MRSA) and methicillin-sensitive staphylococcus aureus (MSSA), remain one of the major global problems.
Microbial metabolomics is used to analyze metabolite differences and identify differences in microbial cellular metabolism in different environments, to screen for metabolites that lead to altered phenotypes and to gain a deeper understanding of the microscopic material changes caused by the external environment. Creative Proteomics provides metabolomics solutions to analyze the metabolic synthesis, metabolic interactions and metabolic regulation of S. aureus, screen for differential metabolites, and facilitate research on S. aureus pathogenesis, infection mechanisms and antimicrobial therapy.